8-K
filed June 15, 2023, 7:59 PM ET
ticker IMNN
CIK 0000749647
other
confidence high
sentiment neutral
materiality 0.30
IMUNON stockholders approve 2018 Stock Incentive Plan amendment, increasing authorized shares to 1,970,000
Imunon, Inc.
- Stockholders approved amendment to 2018 Stock Incentive Plan, increasing shares available from 940,000 to 1,970,000.
- Re-elected directors Frederick J. Fritz and Christine A. Pellizzari to serve until 2026 Annual Meeting.
- Ratified WithumSmith+Brown as independent auditor for fiscal year 2023.
- Advisory Say-on-Pay vote approved; future Say-on-Pay votes set for every year.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Imunon, Inc. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation.
- Proposal
- say on pay frequency
- Outcome
- passed
Exact text from the filing
The proposal to approve, on an advisory basis, the frequency by which future advisory votes on executive compensation will occur was approved for every year based upon the following votes: 1 Year 2 Year 3 Year Abstain Broker Non-Votes 1,230,351 66,870 652,857 58,332 1,969,160
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Imunon, Inc. shareholders approved Advisory vote on 2022 compensation of named executive officers.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
The proposal to approve, on an advisory basis, the 2022 compensation of the Company’s named executive officers (“Say-on-Pay”), was approved based upon the following votes: For Against Abstain Broker Non-Votes 1,447,831 244,474 316,105 1,969,160
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Imunon, Inc. shareholders approved Ratify the appointment of WithumSmith+ Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-31
Exact text from the filing
The proposal, by the audit committee of the board of directors of the Company, to ratify the appointment of WithumSmith+ Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2023, as described in the proxy materials, was approved by the stockholders. The voting results were the following: For Against Abstain 3,752,493 177,797 47,280
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Imunon, Inc. shareholders approved Approve amendment to the 2018 Stock Incentive Plan (increase share limit to 1,970,000 shares).
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
The proposal to approve an amendment to the Stock Plan was approved based on the following votes: For Against Abstain Broker Non-Votes 1,265,154 682,773 60,483 1,969,160
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Imunon, Inc. shareholders approved Election of Directors.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
Each of the individuals listed below was elected, by a majority of the votes cast at the Annual Meeting and entitled to vote on the election of directors, to serve on the Board of Directors until the 2026 Annual Meeting of Stockholders. Nominee For Withheld Broker Non-Votes Frederick J. Fritz 1,384,165 624,245 1,969,160 Christine A. Pellizzari 1,833,554 174,856 1,969,160
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.